Intradialytic Resistance Training in Haemodialysis Patients

Chronic Kidney Disease Requiring Chronic Dialysis Clinical Trial

— IRTHEP  

Official title:

Effect of Intradialytic Resistance Training on Circulatory miRNA Profile and Muscle Strength in Haemodialysis Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03511924
• Other study ID #: PJSU-JR
• Status: Completed
• Phase: N/A
• Start date: January 11, 2018
• Est. completion date: January 31, 2020

Study information

• Verified date: March 2020
• Source: Pavol Jozef Safarik University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The study will investigate the effects of an intradialytic resistance training on miRNA´s expression and muscle strength in haemodialysis patients.

Description:

Chronic kidney disease (CKD) is accompanied by distortions of immune functions and acceleration of inflammation processes. Regular exercise has shown great potential for improving the health-related parameters of CKD patients. Moreover, muscle strength is considered to be an important predictor of protein- and energy- wasting, inflammation, quality of life and mortality in CKD patients. The behaviour and individual variability of adaptation to regular, controlled, supervised physical activities in CKD patients are not well defined and understood. The understanding of molecular adaptation mechanisms, represented by the epigenetic impact of exercise on renal specific miRNA´s expression, is necessary for future improvements in clinical practice. Monitoring pro- and anti-inflammation genes activity, their transcription factors and expression of miRNA molecules (influencing the signalling pathways of specific genes) will enable us to draft a new transcription and translation model for exercise-induced adaptation in CKD patients. Additionally, our results will indicate the clinical value of selected markers for the diagnostics and prognostics of disease.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 90
• Est. completion date: January 31, 2020
• Est. primary completion date: January 31, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 30 Years and older

Eligibility

Inclusion Criteria:

• All patients over 30 years of age, diagnosed with chronic kidney disease, treated with haemodialysis are eligible for our study.

Exclusion Criteria:

• Lower extremity amputation, severe dementia or retardation, acute intercurrent disease and probability of one year mortality higher than 25 % according to Charlson Comorbidity Index (CCI) are the exclusion criteria for participation in the study.

Related Conditions & MeSH terms

• Chronic Kidney Disease Requiring Chronic Dialysis
• Kidney Diseases
• Renal Insufficiency, Chronic

Intervention

Behavioral:
• Intradialytic resistance training
Progressive resistance training programme performed during haemodialysis, taking into account subject´s medical review summarizing: A. full medical history, B. clinical examination including cardiovascular assessment, C. detailed medication usage history, D. review of recent biochemistry and haematology records and results of lower extremity muscle strength assessments. Construction of intradialytic training programme followed recommendations published by the Exercise & Sports Science Australia (Smart et al., 2013).

Locations

Country	Name	City	State
Slovakia	Fresenius Medical Care - Dialysis Services Košice, Slovakia	Košice

Sponsors (3)

Lead Sponsor	Collaborator
Pavol Jozef Safarik University	Dialysis Services Fresenius Medical Care Slovakia, Private Health Institution Logman - Logman East

Country where clinical trial is conducted

Slovakia, 

References & Publications (1)

Smart NA, Williams AD, Levinger I, Selig S, Howden E, Coombes JS, Fassett RG. Exercise & Sports Science Australia (ESSA) position statement on exercise and chronic kidney disease. J Sci Med Sport. 2013 Sep;16(5):406-11. doi: 10.1016/j.jsams.2013.01.005. Epub 2013 Feb 21. Review. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Satisfaction with Life Scale	The Satisfaction With Life Scale will be used for measurements of the life satisfaction component of subjective well-being.	1-5 days before the intervention
Other	Multidimensional Scale of Perceived Social Support	The Multidimensional Scale of Perceived Social Support will be used to measure how much support a parent feels they get from family, friends and significant others.	1-5 days before the intervention
Other	Health literacy	The Health literacy level will be assessed using The Health Literacy Questionnaire and The Brief Health Literacy survey. This questionnaire comprises nine domains to provide a detailed profile of health literacy of populations, groups or patients of interest. The HLQ is divided into two parts which differ in response categories. Part 1 (domains 1-5) has 4 response categories rating the extent of agreement from 1 to 4. Part 2 (domains 6-9) has 5 response categories rating the level of difficulty from cannot do or always difficult (1), to always easy (5). Each domain was scored as the average of the item scores. The score ranges from 1 to 4 or 1 to 5 respectively, a higher score indicating higher level of health literacy.	1-5 days before the intervention
Other	Karnofsky Performance Status	The Karnofsky Performance Status (KPS) scale will be used to assess self-sufficiency and functional capacity of patients on haemodialysis. KPS determines functional impairment in the performance of activities of daily living.	1-5 days before the intervention
Other	Subjective Global Assessment	The nutritional status of patients will be assessed by Subjective Global Assessment method.	1-5 days before the intervention
Primary	Change in lower extremity muscle strength	Change in maximal voluntary force produced during knee extension, leg flexion, extension and hip abduction, adduction will be assessed by dynamometer	Before the intervention, 1-5 days after the completion of the 12-week intervention and after 3 months follow up
Secondary	Change in activity of circulatory miRNA molecules involved in TRIM63 and IGF-1 signalling pathways	Blood plasma will be collected for miRNAs analysis. We will analyze the activity of miRNAs involved in TRIM63 and IGF-1 signalling pathways for better definitions of chronic renal insufficiency and muscular adaptation following progressive resistance training. For miRNA analysis, we selected circulatory miRNA´s which were previously connected with regulation of calcium metabolism, calcification processes, protein-energy wasting, muscle mass and functions	Before the intervention and 1-5 days after the completion of 12-week intervention
Secondary	Change in renal specific clinical data	Clinical data will be collected from the medical documentation of patients. The extracted database will contain patient´s nephrological diagnosis profile, data about the presence of other diagnosis and comorbidities, body composition parameters and standard dialysis biochemistry, haematology and dialysis adequacy measures.	Before the intervention, 1-5 days after the completion of the 12-week intervention and after 3 months follow up
Secondary	Change in score on the Hospital Anxiety and Depression Scale	The Hospital Anxiety and Depression Scale (HADS) will be used to assess states of depression and anxiety in the setting of a hospital medical outpatient clinic. The HADS consists of two subscales, subscale for anxiety and subscale for depression. Both subscales contains seven items and each item is rated on a four-point scale (numeric score range from 0 to 3 points). Maximal score for both subscales is 21, minimal score is 0. Scores of 11 or more on either subscale are considered to be a significant indicator of psychological morbidity. Scores between 8 and 10 represents "borderline" and scores between 0 and 7 represents "normal" indication of anxiety and depression.	Before the intervention and 1-5 days after the completion of 12-week intervention
Secondary	Change in score on the Kidney Disease Quality of Life	Kidney Disease Quality of Life (KDQOL™) instrument will be used to assess generic and kidney-disease targeted aspects of quality of life (self-rated health, self-rated change of health status, physical and mental component) of patients on haemodialysis.	Before the intervention and 1-5 days after the completion of 12-week intervention